Back to top
more

Shattuck Labs (STTK)

(Delayed Data from NSDQ)

$3.01 USD

3.01
1,249

-0.02 (-0.66%)

Updated Mar 24, 2023 11:32 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.52%
2Buy18.26%
3Hold9.60%
4Sell5.38%
5Strong Sell2.61%
S&P50010.68%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (88 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for STTK

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Shattuck Labs, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Assets          
Cash & Equivalents 161 269 335 39 NA
Receivables 0 0 0 0 NA
Notes Receivable 0 0 0 0 NA
Inventories 0 0 0 0 NA
Other Current Assets 23 19 10 3 NA
Total Current Assets 185 288 346 42 NA
Net Property & Equipment 18 10 3 2 NA
Investments & Advances 0 0 0 0 NA
Other Non-Current Assets 0 0 0 0 NA
Deferred Charges 0 0 0 0 NA
Intangibles 0 0 0 0 NA
Deposits & Other Assets 3 0 0 0 NA
Total Assets 205 299 349 45 NA
Liabilities & Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Notes Payable 0 0 0 0 NA
Accounts Payable 7 10 2 3 NA
Current Portion Long-Term Debt 0 0 0 0 NA
Current Portion Capital Leases 0 0 0 0 NA
Accrued Expenses 18 15 7 4 NA
Income Taxes Payable 0 0 0 0 NA
Other Current Liabilities 0 0 8 13 NA
Total Current Liabilities 25 25 17 20 NA
Mortgages 0 0 0 0 NA
Deferred Taxes/Income 0 2 22 10 NA
Convertible Debt 0 0 0 0 NA
Long-Term Debt 0 0 0 0 NA
Non-Current Capital Leases 0 0 0 0 NA
Other Non-Current Liabilities 0 0 0 0 NA
Minority Interest (Liabilities) 0 0 0 0 NA
Total Liabilities 29 27 39 30 NA
Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Preferred Stock 0 0 0 49 NA
Common Stock (Par) 0 0 0 0 NA
Capital Surplus 396 389 382 1 NA
Retained Earnings -219 -117 -72 -35 NA
Other Equity -1 -1 0 0 NA
Treasury Stock 0 0 0 0 NA
Total Shareholder's Equity 176 272 310 15 NA
Total Liabilities & Shareholder's Equity 205 299 349 45 NA
Total Common Equity 176 272 310 -35 0
Shares Outstanding 42.30 42.20 41.70 NA NA
Book Value Per Share 4.16 6.44 7.43 0.00 0.00

Fiscal Year End for Shattuck Labs, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Assets          
Cash & Equivalents 161 185 214 239 269
Receivables 0 0 0 0 0
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 23 16 15 16 19
Total Current Assets 185 202 229 255 288
Net Property & Equipment 18 18 19 12 10
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 0 0 0 0 0
Deposits & Other Assets 3 3 3 3 0
Total Assets 205 223 251 270 299
Liabilities & Shareholders Equity 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Notes Payable 0 0 0 0 0
Accounts Payable 7 3 6 3 10
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 18 16 19 14 15
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 25 19 24 17 25
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 2
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 29 24 29 22 27
Shareholders Equity 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 396 394 393 391 389
Retained Earnings -219 -194 -169 -142 -117
Other Equity -1 -1 -1 -1 -1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 176 199 223 249 272
Total Liabilities & Shareholder's Equity 205 223 251 270 299
Total Common Equity 176 199 223 249 272
Shares Outstanding 42.30 42.30 42.30 42.30 42.20
Book Value Per Share 4.16 4.71 5.26 5.89 6.44